Niche Presbyopia Target a highly specific, large patient base focused on presbyopia who are seeking non-invasive, at-home treatment options. Opportunities exist to partner with ophthalmology clinics, optometrists, and vision health networks to highlight TVT as a convenient alternative that reduces dependence on reading glasses.

Home-Treatment Advantage Position TVT as a home-based therapy that lowers in-clinic visit requirements and appeals to busy or remote patients. Develop sales playbooks aimed at direct-to-consumer channels and telehealth partnerships to expand reach beyond traditional eye care settings.

Dual-Outcome Benefit Emphasize the unique benefit of improving both near and distance vision without sacrificing one for the other. Use this differentiator to engage eye care professionals and highlight potential for higher patient satisfaction and retention compared with conventional presbyopia solutions.

Early Adoption.ready Capitalize on rapid initial results (3-5 days) to build case studies and patient stories. Create clinician-approved evidence packs and digital testimonials to accelerate clinician referrals and patient conversions in clinics and vision centers.

Funding & Growth Leverage the recent $5M funding and modest revenue scale to pursue strategic partnerships with mid to large eye care networks, contract manufacturers, or distributors. Focus on scaled pilots with clear ROI metrics to attract larger health systems and demonstrate market traction.